The 13-valent pneumococcal conjugate vaccine (PCV13) does not appear to provide much protection on combined invasive disease due to the six PCV13 non-PCV7 serotypes 1, 3, 5, 6A, 7F, and 19A in Kuwait during 2010–2019

The 13-valent pneumococcal conjugate vaccine (PCV13) does not appear to provide much protection on combined invasive disease due to the six PCV13 non-PCV7 serotypes 1, 3, 5, 6A, 7F, and 19A in Kuwait during 2010–2019

Kuwait started immunizing children <2 y age with the 7-valent pneumococcal conjugate vaccine, PCV7 from August 2007. PCV7 was replaced by the 13-valent conjugate vaccine, PCV13 from August 2010. In a previous analysis of the results for the period, August 2010–July 2013 (period II), there was no...

Full description

Bibliographic Details
Main Authors: Eiman Mokaddas, Shabeera Syed, M. John Albert
Format: Article
Language:English
Published: Taylor & Francis Group 2021-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
pneumococcal conjugate vaccines pcv7 and pcv13
non-pcv7 serotypes of pcv13
invasive disease
poor protection
kuwait
Online Access:http://dx.doi.org/10.1080/21645515.2021.1968216

Similar Items

Similar Items